SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-06-230387
Filing Date
2006-11-09
Accepted
2006-11-09 16:19:27
Documents
6
Period of Report
2006-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d10q.htm 10-Q 254376
2 DEVELOPMENT AND LICENSE AGREEMENT dex1056.htm EX-10.56 264079
3 SECTION 302 CEO CERTIFICATION dex311.htm EX-31.1 9564
4 SECTION 302 CFO CERTIFICATION dex312.htm EX-31.2 9582
5 SECTION 906 CEO CERTIFICATION dex321.htm EX-32.1 2989
6 SECTION 906 CFO CERTIFICATION dex322.htm EX-32.2 3048
  Complete submission text file 0001193125-06-230387.txt   545109
Mailing Address 1700 PERIMETER PARK DRIVE MORRISVILLE NC 27560
Business Address 1700 PERIMETER PARK DRIVE MORRISVILLE NC 27560 (919) 862-1000
SALIX PHARMACEUTICALS LTD (Filer) CIK: 0001009356 (see all company filings)

IRS No.: 943267443 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-23265 | Film No.: 061202500
SIC: 2834 Pharmaceutical Preparations